$CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Stock
$celz
2018 Q1 Form 10-Q Financial Statement
#000114420418030097 Filed on May 21, 2018
Income Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| Revenue | $9.600K | $0.00 |
| YoY Change | ||
| Cost Of Revenue | $2.400K | $0.00 |
| YoY Change | ||
| Gross Profit | $7.200K | $0.00 |
| YoY Change | ||
| Gross Profit Margin | 75.0% | |
| Selling, General & Admin | $200.0K | $180.0K |
| YoY Change | 11.11% | 28.57% |
| % of Gross Profit | 2777.78% | |
| Research & Development | $3.200K | $59.83K |
| YoY Change | -94.65% | 1271.01% |
| % of Gross Profit | 44.44% | |
| Depreciation & Amortization | $10.00K | $0.00 |
| YoY Change | ||
| % of Gross Profit | 138.89% | |
| Operating Expenses | $211.4K | $240.8K |
| YoY Change | -12.22% | 63.7% |
| Operating Profit | -$204.2K | -$240.8K |
| YoY Change | -15.21% | 62.9% |
| Interest Expense | $191.3K | $2.505K |
| YoY Change | 7537.05% | |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$7.382M | -$2.505K |
| YoY Change | 294605.15% | |
| Pretax Income | -$7.587M | -$243.4K |
| YoY Change | 3017.55% | 62.23% |
| Income Tax | $0.00 | |
| % Of Pretax Income | ||
| Net Earnings | -$7.587M | -$243.4K |
| YoY Change | 3017.55% | 64.6% |
| Net Earnings / Revenue | -79026.88% | |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$30.23K | -$1.736K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 244.8M shares | 105.0M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $100.0K | $100.0K |
| YoY Change | 0.0% | |
| Cash & Equivalents | $102.3K | $98.12K |
| Short-Term Investments | ||
| Other Short-Term Assets | ||
| YoY Change | ||
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $9.600K | |
| Other Receivables | $0.00 | |
| Total Short-Term Assets | $111.9K | $98.12K |
| YoY Change | 14.06% | |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | ||
| YoY Change | ||
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $178.1K | $98.01K |
| YoY Change | 81.71% | |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $111.9K | $98.12K |
| Total Long-Term Assets | $178.1K | $98.01K |
| Total Assets | $290.0K | $196.1K |
| YoY Change | 47.86% | |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $230.0K | $96.88K |
| YoY Change | 137.41% | 384.4% |
| Accrued Expenses | $30.00K | $6.891K |
| YoY Change | 335.35% | |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $250.0K | $100.0K |
| YoY Change | 150.0% | -33.33% |
| Long-Term Debt Due | $260.0K | |
| YoY Change | ||
| Total Short-Term Liabilities | $8.220M | $468.9K |
| YoY Change | 1653.15% | 175.81% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $30.00K |
| YoY Change | -100.0% | 50.0% |
| Other Long-Term Liabilities | $0.00 | $0.00 |
| YoY Change | ||
| Total Long-Term Liabilities | $0.00 | $30.00K |
| YoY Change | -100.0% | 50.0% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $8.220M | $468.9K |
| Total Long-Term Liabilities | $0.00 | $30.00K |
| Total Liabilities | $8.230M | $495.8K |
| YoY Change | 1559.94% | 160.95% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$1.010M | |
| YoY Change | ||
| Common Stock | $710.2K | |
| YoY Change | 610.25% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$7.934M | -$300.0K |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $290.0K | $196.1K |
| YoY Change | 47.86% |
Cashflow Statement
| Concept | 2018 Q1 | 2017 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$7.587M | -$243.4K |
| YoY Change | 3017.55% | 64.6% |
| Depreciation, Depletion And Amortization | $10.00K | $0.00 |
| YoY Change | ||
| Cash From Operating Activities | -$164.9K | -$223.7K |
| YoY Change | -26.28% | 459.37% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $0.00 | |
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $0.00 | |
| YoY Change | ||
| Cash From Investing Activities | $0.00 | $0.00 |
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 253.6K | $100.0K |
| YoY Change | 153.55% | 100.0% |
| NET CHANGE | ||
| Cash From Operating Activities | -164.9K | -$223.7K |
| Cash From Investing Activities | 0.000 | 0.000 |
| Cash From Financing Activities | 253.6K | $100.0K |
| Net Change In Cash | 88.61K | -$123.7K |
| YoY Change | -171.61% | -1337.49% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$164.9K | -$223.7K |
| Capital Expenditures | $0.00 | |
| Free Cash Flow | -$223.7K | |
| YoY Change | 459.37% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
10800 | USD |
| CY2018Q1 | us-gaap |
Assets Current
AssetsCurrent
|
111910 | USD |
| CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
18498 | USD |
| CY2018Q1 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
10800 | USD |
| CY2017Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
125000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
18268 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
44250 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
253550 | USD |
| CY2018Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
88613 | USD |
| CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
13697 | USD |
| CY2018Q1 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
3704 | USD |
| CY2017Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
3211 | USD |
| CY2018Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
179363 | USD |
| CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
184649 | USD |
| CY2018Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2018Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
258950 | USD |
| CY2017Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
251748 | USD |
| CY2018Q1 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
125000 | USD |
| CY2018Q1 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
7045971 | USD |
| CY2017Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
1309190 | USD |
| CY2018Q1 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
0 | USD |
| CY2017Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
915 | USD |
| CY2018Q1 | us-gaap |
Revenues
Revenues
|
9600 | USD |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3200 | USD |
| CY2018Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
202930 | USD |
| CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
211416 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7586580 | USD |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
188131817 | shares |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.04 | |
| CY2018Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5286 | USD |
| CY2017Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2017Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
59831 | USD |
| CY2017Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
178378 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2637 | USD |
| CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
240846 | USD |
| CY2018Q1 | us-gaap |
Interest Expense
InterestExpense
|
191308 | USD |
| CY2017Q1 | us-gaap |
Interest Expense
InterestExpense
|
2505 | USD |
| CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7382364 | USD |
| CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2505 | USD |
| CY2018Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
7036772 | USD |
| CY2017Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-204216 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-240846 | USD |
| CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-7586580 | USD |
| CY2017Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-243351 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1877 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-4135 | USD |
| CY2018Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
102310 | USD |
| CY2018Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
200 | USD |
| CY2018Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
30494 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
2505 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-17500 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
100000 | USD |
| CY2018Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
6505216 | USD |
| CY2018Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
7045971 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-123749 | USD |
| CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
221868 | USD |
| CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
98119 | USD |
| CY2017Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1466 | USD |
| CY2018Q1 | celz |
Fair Value Of Warrants Issued In Private Placement
FairValueOfWarrantsIssuedInPrivatePlacement
|
0 | USD |
| CY2017Q1 | celz |
Fair Value Of Warrants Issued In Private Placement
FairValueOfWarrantsIssuedInPrivatePlacement
|
5546 | USD |
| CY2018Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
800 | USD |
| CY2017Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
254350 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
| CY2018Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
157340 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| CY2018Q1 | us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
-7036772 | USD |
| CY2017Q1 | us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
0 | USD |
| CY2017Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
50000 | USD |
| CY2018Q1 | us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0 | pure |
| CY2018Q1 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.0203 | pure |
| CY2018Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
752230 | USD |
| CY2018Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
502000 | USD |
| CY2018Q1 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
479000000 | shares |
| CY2018Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
9600 | USD |
| CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4801 | USD |
| CY2018Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2018Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2018Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
400940232 | shares |
| CY2018Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
400340232 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
115399226 | shares |
| CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
114799226 | shares |
| CY2018Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2400 | USD |
| CY2017Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
| CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
7200 | USD |
| CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
| CY2018Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-154284 | USD |
| CY2017Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4799 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | USD |
| CY2018Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1887052 | USD |
| CY2017Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
| CY2017Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
1309190 | USD |
| CY2018Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
|
900772 | USD |
| CY2018Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
-1669207 | USD |
| CY2018Q1 | celz |
Working Capital Deficit
WorkingCapitalDeficit
|
8109483 | USD |
| CY2018Q1 | celz |
Reimbursement Of Management Fees
ReimbursementOfManagementFees
|
35000 | USD |
| CY2017Q4 | celz |
Management Reimbursement Agreement Description
ManagementReimbursementAgreementDescription
|
At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days’ prior written notice. | |
| CY2018Q1 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
478564572 | shares |
| CY2018Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
494309 | USD |
| CY2018Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
262500 | USD |
| CY2018Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
756809 | USD |
| CY2018Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
54200 | USD |
| CY2018Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
4000 | USD |
| CY2018Q1 | us-gaap |
Legal Fees
LegalFees
|
2000 | USD |
| CY2018Q1 | celz |
Increase In Principal Balance Due To Penalty Provision
IncreaseInPrincipalBalanceDueToPenaltyProvision
|
12500 | USD |
| CY2017Q1 | celz |
Increase In Principal Balance Due To Penalty Provision
IncreaseInPrincipalBalanceDueToPenaltyProvision
|
0 | USD |
| CY2018Q1 | celz |
Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
|
0 | USD |
| CY2017Q1 | celz |
Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
|
100000 | USD |
| CY2018Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><b><i>Use of Estimates</i></b> – The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
22426087 | shares |
| CY2018Q1 | celz |
Class Of Warrant Issued
ClassOfWarrantIssued
|
32750000 | shares |
| CY2018Q1 | celz |
Warrant Exercises
WarrantExercises
|
-105212584 | shares |
| CY2018Q1 | celz |
Warrant Antidilution And Modification
WarrantAntidilutionAndModification
|
159727241 | shares |
| CY2018Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
95490744 | shares |
| CY2018Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.00084 | |
| us-gaap |
Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
|
From March 2017 through March 2018, the Company issued 33,116,667 warrants to two parties associated with the issuance of convertible notes. The issued warrants expire 5 years from the date of issuance and have anti-dilution and re-pricing features. | ||
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-164937 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-223749 | USD |
| CY2018Q1 | celz |
Warrant Forfeitures Or Cancellations
WarrantForfeituresOrCancellations
|
-15200000 | shares |
